ロード中...
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients
Aims: To measure pimecrolimus blood concentrations and to evaluate tolerability and efficacy in children and infants treated topically for atopic dermatitis with pimecrolimus cream 1% for three weeks. Methods: Three open label, non-controlled, multiple topical dose studies were conducted in children...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1719352/ https://ncbi.nlm.nih.gov/pubmed/14612358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/adc.88.11.969 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|